• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    Sponsored Content
    Center for Global Development
    • News
    • From our partner: Center for Global Development

    What happened to noncommunicable diseases?

    Since last year’s high-level meeting, only a 25 percent reduction in premature mortality has been set. No other measurable goals to reduce NCDs were agreed upon, Victoria Fan of the Center for Global Development and Laura Khan of Princeton University write in this joint post.

    By Devex Editor // 20 September 2012

    EDITOR’S NOTE: Since last year’s high-level meeting, only a 25 percent reduction in premature mortality has been set. No other measurable goals to reduce NCDs were agreed upon, Victoria Fan of the Center for Global Development and Laura Khan of Princeton University write in this joint post for the Global Health Policy blog.

    One year ago, the United Nations held a high-level meeting on non-communicable disease (NCD) prevention and control that culminated in a GeneralAssembly Resolution 66/2 to adopt a 13-page “political declaration” to “address the prevention and control of non-communicable diseases worldwide.” The event presented a united front against NCDs and its flashiness garnered lots of media attention.  But one year later, where has the attention and commitment to NCDs gone?

    NCDs are still a major health burden worldwide. They include cardiovascular disease, most cancers, diabetes and chronic respiratory disease. No longer diseases of affluence, NCDs kill about 57 million people globally each year, 80 percent of whom live in low and middle-income countries.

    But despite last year’s high-level meeting, no measureable goals to reduce NCDs, such as targets for reduced mortality or increased access to medicines, were agreed upon — only until the recent World Health Assembly this past spring adopted a global target of a 25% reduction in premature mortality. Moreover, there were no noteworthy financial commitments resulting from the meeting, and there has been no increase or even change in donor funding levels (even though donor funding for NCDs increased slightly from 2001 to 2008 as my colleagues Rachel Nugent and Andrea Feigl showed).

    The last time any disease received such high-level political attention was probably ten years earlier – in 2001 – at the high-level UN General Assembly Special Session on HIV/AIDS.  And the biggest global health funding agency today, the Global Fund, was created after a G8 meeting that supported efforts to reduce HIV/AIDS, tuberculosis, and malaria. In comparison, subsequent attention and action after the NCD Summit last year has been paltry. Why is this the case?

    Is it the bad economic climate or lack of political attention? Global health researchers and advocates have frequently noted the dim financial outlook of development assistance for health and most attention is still focused on the three “big” diseases of HIV/AIDS, malaria, and tuberculosis (perhaps with little room left over for these ‘newer’ areas of NCDs and child health).

    How about too many global health agendas – or the ‘umbrella’ of ‘universal health coverage’ resulting in too little attention to any one disease area? Or what about NCDs not being as ‘scary’, ‘new’, or ‘sexy’ as HIV/AIDS – especially if our image of NCDs is that of an obese smoker? Maybe agendas to fight NCDs are even being hindered by Big Tobacco, Big Food and Big Soda. To muddy the water even more, many so-called ‘non-communicable’ diseases such as cancer actually have an infectious origin, like  liver cancer (hepatitis), stomach cancer (H. pylori infection), and cervical cancer (HPV). Finally, maybe the complex combination of diseases subsumed under the label of NCDs are just too anonymous to excite action?

    As Jim Kim noted at the recent International AIDS Society (IAS) Conference, it is the AIDS activists who have led the way in developing and promoting the HIV/AIDS agenda. NCD advocates have much to learn from the HIV/AIDS world.  But what’s remarkable is that HIV/AIDS advocates are now supporting the NCDs agenda – especially as HIV/AIDS becomes a chronic and long-term (i.e. lifelong) condition in many settings (see here, here, and here). Data presented at the IAS Conference also indicates that people with HIV/AIDS are at greater risk for some NCDs. Yet much of the HIV/AIDS interest in NCDs may be fairly self-interested and also mainly clinical. The crude idea would be that, since a patient infected with HIV/AIDS is already coming to the clinic anyway, she or he can also be screened for cancer and other NCDs – since HIV/AIDS funding is earmarked and restricted to those patients with HIV/AIDS or those at risk of it. The ethical implications of this approach, however – from the concentration of financial resources on a (relatively small) fraction of the population – are very concerning. Others including my colleagues Amanda Glassman and Tom Bollyky have written on an innovative approach ofcash on delivery for tobacco control and other public health policies including thoughtful priority setting that are likely to have higher leverage and better value for money than clinical approaches.

    Moving forward, will NCDs be brushed aside like yet another global health flavor-of-the-month, come and gone? Or is there another way to rethink entirely how global health priorities are set? For starters we need better priority setting which must also be incorporated into discussions of universal health coverage, the current topic of interest. It’s hard to dispute that global health priorities needs some rethinking.

    Republished with permission from the Center for Global Development. Read the original article.

    • Global Health
    • Funding
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Devex Editor

      Devex Editor

      Thanks a lot for your interest in Devex News. To share news and views, story ideas and press releases, please email editor@devex.com. We look forward to hearing from you.

    Search for articles

    Related Jobs

    • Manager, Regenerative Agriculture
      The Rockefeller Foundation
      New York City, New York, United States | New York, United States | United States | North America
    • Senior Officer, Major Gifts & Planned Giving
      Fos Feminista
      United States | North America
    • Digital Fundraising Lead (Hybrid)
      London, United Kingdom | United Kingdom | Western Europe
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      FCDO's top development contractors in 2024/25
    • 3
      Strengthening health systems by measuring what really matters
    • 4
      How AI-powered citizen science can be a catalyst for the SDGs
    • 5
      Opinion: India’s bold leadership in turning the tide for TB

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    Global HealthNoncommunicable diseases: A policy success but implementation failure

    Noncommunicable diseases: A policy success but implementation failure

    78th World Health AssemblyNoncommunicable disease political declaration needs ‘more teeth’

    Noncommunicable disease political declaration needs ‘more teeth’

    78th World Health Assembly6 key issues to watch at the 78th World Health Assembly

    6 key issues to watch at the 78th World Health Assembly

    78th World Health AssemblyWHA watch list: Who to follow at this year’s World Health Assembly

    WHA watch list: Who to follow at this year’s World Health Assembly

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement